ChartRow logo
Share this page
RXRX
$3.47-16.71%
as of close, Oct 16, 2026
☾ AH $3.47 -16.71%
Recursion Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.06%Nasdaq Composite 0.006%US Stock Market 0.003%Russell 3000 0.002%
PeersMRNALLYMDTUNHJNJTMO

Recursion Pharmaceuticals Inc. trailing returns

How Recursion Pharmaceuticals Inc. (RXRX) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-16.7%+0.0%-16.7%—
5 days-20.5%+0.0%-20.5%-20.5%Oct 16
1 month+8.6%+0.0%+8.6%-27.5%Oct 16
YTD-15.3%+0.0%-15.3%-42.7%Mar 30
1 year-45.5%+0.0%-45.5%-57.5%Mar 2026
5 years-28.9%+0.0%-28.9%-81.8%-86.3%Mar 2026
Since inception (2021)-33.0%+0.0%-33.0%-88.9%-93.1%Mar 2026

Growth of RXRX#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-28.9%/year · -81.8%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in RXRX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Recursion Pharmaceuticals Inc.'s return since inception?
Since 2021, Recursion Pharmaceuticals Inc. (RXRX) has compounded at about -33.0% a year — -88.9% in total.

More on Recursion Pharmaceuticals Inc.